Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Hematologic Malignancies Market Size Growth Rate by Type (2014-2025) 1.4.2 Leukemia 1.4.3 Lymphoma 1.4.4 Multiple Myeloma 1.4.5 Others 1.5 Market by Application 1.5.1 Global Hematologic Malignancies Market Share by Application (2014-2025) 1.5.2 Chemotherapy 1.5.3 Radiotherapy 1.5.4 Immunotherapy 1.5.5 Stem Cell Transplantation 1.5.6 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Hematologic Malignancies Market Size 2.2 Hematologic Malignancies Growth Trends by Regions 2.2.1 Hematologic Malignancies Market Size by Regions (2014-2025) 2.2.2 Hematologic Malignancies Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Hematologic Malignancies Market Size by Manufacturers 3.1.1 Global Hematologic Malignancies Revenue by Manufacturers (2014-2019) 3.1.2 Global Hematologic Malignancies Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Hematologic Malignancies Market Concentration Ratio (CR5 and HHI) 3.2 Hematologic Malignancies Key Players Head office and Area Served 3.3 Key Players Hematologic Malignancies Product/Solution/Service 3.4 Date of Enter into Hematologic Malignancies Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Hematologic Malignancies Market Size by Type (2014-2019) 4.2 Global Hematologic Malignancies Market Size by Application (2014-2019) 5 United States 5.1 United States Hematologic Malignancies Market Size (2014-2019) 5.2 Hematologic Malignancies Key Players in United States 5.3 United States Hematologic Malignancies Market Size by Type 5.4 United States Hematologic Malignancies Market Size by Application 6 Europe 6.1 Europe Hematologic Malignancies Market Size (2014-2019) 6.2 Hematologic Malignancies Key Players in Europe 6.3 Europe Hematologic Malignancies Market Size by Type 6.4 Europe Hematologic Malignancies Market Size by Application 7 China 7.1 China Hematologic Malignancies Market Size (2014-2019) 7.2 Hematologic Malignancies Key Players in China 7.3 China Hematologic Malignancies Market Size by Type 7.4 China Hematologic Malignancies Market Size by Application 8 Japan 8.1 Japan Hematologic Malignancies Market Size (2014-2019) 8.2 Hematologic Malignancies Key Players in Japan 8.3 Japan Hematologic Malignancies Market Size by Type 8.4 Japan Hematologic Malignancies Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Hematologic Malignancies Market Size (2014-2019) 9.2 Hematologic Malignancies Key Players in Southeast Asia 9.3 Southeast Asia Hematologic Malignancies Market Size by Type 9.4 Southeast Asia Hematologic Malignancies Market Size by Application 10 India 10.1 India Hematologic Malignancies Market Size (2014-2019) 10.2 Hematologic Malignancies Key Players in India 10.3 India Hematologic Malignancies Market Size by Type 10.4 India Hematologic Malignancies Market Size by Application 11 Central & South America 11.1 Central & South America Hematologic Malignancies Market Size (2014-2019) 11.2 Hematologic Malignancies Key Players in Central & South America 11.3 Central & South America Hematologic Malignancies Market Size by Type 11.4 Central & South America Hematologic Malignancies Market Size by Application 12 International Players Profiles 12.1 Pfizer, Inc. 12.1.1 Pfizer, Inc. Company Details 12.1.2 Company Description and Business Overview 12.1.3 Hematologic Malignancies Introduction 12.1.4 Pfizer, Inc. Revenue in Hematologic Malignancies Business (2014-2019) 12.1.5 Pfizer, Inc. Recent Development 12.2 F. Hoffmann-LA Roche ltd 12.2.1 F. Hoffmann-LA Roche ltd Company Details 12.2.2 Company Description and Business Overview 12.2.3 Hematologic Malignancies Introduction 12.2.4 F. Hoffmann-LA Roche ltd Revenue in Hematologic Malignancies Business (2014-2019) 12.2.5 F. Hoffmann-LA Roche ltd Recent Development 12.3 Sanofi-Aventis 12.3.1 Sanofi-Aventis Company Details 12.3.2 Company Description and Business Overview 12.3.3 Hematologic Malignancies Introduction 12.3.4 Sanofi-Aventis Revenue in Hematologic Malignancies Business (2014-2019) 12.3.5 Sanofi-Aventis Recent Development 12.4 Bristol-Myers Squibb Company 12.4.1 Bristol-Myers Squibb Company Company Details 12.4.2 Company Description and Business Overview 12.4.3 Hematologic Malignancies Introduction 12.4.4 Bristol-Myers Squibb Company Revenue in Hematologic Malignancies Business (2014-2019) 12.4.5 Bristol-Myers Squibb Company Recent Development 12.5 AbbVie, Inc. 12.5.1 AbbVie, Inc. Company Details 12.5.2 Company Description and Business Overview 12.5.3 Hematologic Malignancies Introduction 12.5.4 AbbVie, Inc. Revenue in Hematologic Malignancies Business (2014-2019) 12.5.5 AbbVie, Inc. Recent Development 12.6 Novartis AG 12.6.1 Novartis AG Company Details 12.6.2 Company Description and Business Overview 12.6.3 Hematologic Malignancies Introduction 12.6.4 Novartis AG Revenue in Hematologic Malignancies Business (2014-2019) 12.6.5 Novartis AG Recent Development 12.7 GlaxoSmithKline PLC 12.7.1 GlaxoSmithKline PLC Company Details 12.7.2 Company Description and Business Overview 12.7.3 Hematologic Malignancies Introduction 12.7.4 GlaxoSmithKline PLC Revenue in Hematologic Malignancies Business (2014-2019) 12.7.5 GlaxoSmithKline PLC Recent Development 12.8 Celgene Corporation 12.8.1 Celgene Corporation Company Details 12.8.2 Company Description and Business Overview 12.8.3 Hematologic Malignancies Introduction 12.8.4 Celgene Corporation Revenue in Hematologic Malignancies Business (2014-2019) 12.8.5 Celgene Corporation Recent Development 12.9 Johnson & Johnson Services, Inc. 12.9.1 Johnson & Johnson Services, Inc. Company Details 12.9.2 Company Description and Business Overview 12.9.3 Hematologic Malignancies Introduction 12.9.4 Johnson & Johnson Services, Inc. Revenue in Hematologic Malignancies Business (2014-2019) 12.9.5 Johnson & Johnson Services, Inc. Recent Development 12.10 Takeda Pharmaceutical Company limited 12.10.1 Takeda Pharmaceutical Company limited Company Details 12.10.2 Company Description and Business Overview 12.10.3 Hematologic Malignancies Introduction 12.10.4 Takeda Pharmaceutical Company limited Revenue in Hematologic Malignancies Business (2014-2019) 12.10.5 Takeda Pharmaceutical Company limited Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Hematologic Malignancies Key Market Segments Table Key Players Hematologic Malignancies Covered Table Global Hematologic Malignancies Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Hematologic Malignancies Market Size Market Share by Type 2014-2025 Figure Leukemia Figures Table Key Players of Leukemia Figure Lymphoma Figures Table Key Players of Lymphoma Figure Multiple Myeloma Figures Table Key Players of Multiple Myeloma Figure Others Figures Table Key Players of Others Table Global Hematologic Malignancies Market Size Growth by Application 2014-2025 (Million US$) Figure Chemotherapy Case Studies Figure Radiotherapy Case Studies Figure Immunotherapy Case Studies Figure Stem Cell Transplantation Case Studies Figure Others Case Studies Figure Hematologic Malignancies Report Years Considered Table Global Hematologic Malignancies Market Size 2014-2025 (Million US$) Figure Global Hematologic Malignancies Market Size and Growth Rate 2014-2025 (Million US$) Table Global Hematologic Malignancies Market Size by Regions 2014-2025 (Million US$) Table Global Hematologic Malignancies Market Size by Regions 2014-2019 (Million US$) Table Global Hematologic Malignancies Market Share by Regions 2014-2019 Figure Global Hematologic Malignancies Market Share by Regions 2014-2019 Figure Global Hematologic Malignancies Market Share by Regions 2019 Table Market Top Trends Table Global Hematologic Malignancies Revenue by Manufacturers (2014-2019) (Million US$) Table Global Hematologic Malignancies Market Share by Manufacturers (2014-2019) Figure Global Hematologic Malignancies Market Share by Manufacturers in 2018 Table Global Hematologic Malignancies Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Hematologic Malignancies Product/Solution/Service Table Date of Enter into Hematologic Malignancies Market Table Mergers & Acquisitions, Expansion Plans Table Global Hematologic Malignancies Market Size by Type (2014-2019) (Million US$) Table Global Hematologic Malignancies Market Size Share by Type (2014-2019) Figure Global Hematologic Malignancies Market Size Market Share by Type (2014-2019) Table Global Hematologic Malignancies Market Size by Application (2014-2019) (Million US$) Table Global Hematologic Malignancies Market Size Share by Application (2014-2019) Figure Global Hematologic Malignancies Market Size Market Share by Application (2014-2019) Figure Global Hematologic Malignancies Revenue Market Share by Application in 2018 Figure United States Hematologic Malignancies Market Size 2014-2019 (Million US$) Table United States Key Players Hematologic Malignancies Revenue (2018-2019) (Million US$) Table United States Key Players Hematologic Malignancies Market Share (2018-2019) Table United States Hematologic Malignancies Market Size by Type (2014-2019) (Million US$) Table United States Hematologic Malignancies Market Share by Type (2014-2019) Table United States Hematologic Malignancies Market Size by Application (2014-2019) (Million US$) Table United States Hematologic Malignancies Market Share by Application (2014-2019) Figure Europe Hematologic Malignancies Market Size 2014-2019 (Million US$) Table Europe Key Players Hematologic Malignancies Revenue (2018-2019) (Million US$) Table Europe Key Players Hematologic Malignancies Market Share (2018-2019) Table Europe Hematologic Malignancies Market Size by Type (2014-2019) (Million US$) Table Europe Hematologic Malignancies Market Share by Type (2014-2019) Table Europe Hematologic Malignancies Market Size by Application (2014-2019) (Million US$) Table Europe Hematologic Malignancies Market Share by Application (2014-2019) Figure China Hematologic Malignancies Market Size 2014-2019 (Million US$) Table China Key Players Hematologic Malignancies Revenue (2018-2019) (Million US$) Table China Key Players Hematologic Malignancies Market Share (2018-2019) Table China Hematologic Malignancies Market Size by Type (2014-20189) (Million US$) Table China Hematologic Malignancies Market Share by Type (2014-2019) Table China Hematologic Malignancies Market Size by Application (2014-2019) (Million US$) Table China Hematologic Malignancies Market Share by Application (2014-2019) Figure Japan Hematologic Malignancies Market Size 2014-2019 (Million US$) Table Japan Key Players Hematologic Malignancies Revenue (2018-2019) (Million US$) Table Japan Key Players Hematologic Malignancies Market Share (2018-2019) Table Japan Hematologic Malignancies Market Size by Type (2014-2019) (Million US$) Table Japan Hematologic Malignancies Market Share by Type (2014-2019) Table Japan Hematologic Malignancies Market Size by Application (2014-2019) (Million US$) Table Japan Hematologic Malignancies Market Share by Application (2014-2019) Figure Southeast Asia Hematologic Malignancies Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Hematologic Malignancies Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Hematologic Malignancies Market Share (2018-2019) Table Southeast Asia Hematologic Malignancies Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Hematologic Malignancies Market Share by Type (2014-2019) Table Southeast Asia Hematologic Malignancies Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Hematologic Malignancies Market Share by Application (2014-2019) Figure India Hematologic Malignancies Market Size 2014-2019 (Million US$) Table India Key Players Hematologic Malignancies Revenue (2018-2019) (Million US$) Table India Key Players Hematologic Malignancies Market Share (2018-2019) Table India Hematologic Malignancies Market Size by Type (2014-2019) (Million US$) Table India Hematologic Malignancies Market Share by Type (2014-2019) Table India Hematologic Malignancies Market Size by Application (2014-2019) (Million US$) Table India Hematologic Malignancies Market Share by Application (2014-2019) Figure Central & South America Hematologic Malignancies Market Size 2014-2019 (Million US$) Table Central & South America Key Players Hematologic Malignancies Revenue (2018-2019) (Million US$) Table Central & South America Key Players Hematologic Malignancies Market Share (2018-2019) Table Central & South America Hematologic Malignancies Market Size by Type (2014-2019) (Million US$) Table Central & South America Hematologic Malignancies Market Share by Type (2014-2019) Table Central & South America Hematologic Malignancies Market Size by Application (2014-2019) (Million US$) Table Central & South America Hematologic Malignancies Market Share by Application (2014-2019) Table Pfizer, Inc. Company Details Table Pfizer, Inc. Revenue in Hematologic Malignancies Business (2014-2019) (Million US$) Figure Pfizer, Inc. Revenue Growth Rate in Hematologic Malignancies Business (2014-2019) Table Pfizer, Inc. Recent Development Table F. Hoffmann-LA Roche ltd Company Details Table F. Hoffmann-LA Roche ltd Revenue in Hematologic Malignancies Business (2014-2019)(Million US$) Figure F. Hoffmann-LA Roche ltd Revenue Growth Rate in Hematologic Malignancies Business (2014-2019) Table F. Hoffmann-LA Roche ltd Recent Development Table Sanofi-Aventis Company Details Table Sanofi-Aventis Revenue in Hematologic Malignancies Business (2014-2019)(Million US$) Figure Sanofi-Aventis Revenue Growth Rate in Hematologic Malignancies Business (2014-2019) Table Sanofi-Aventis Recent Development Table Bristol-Myers Squibb Company Company Details Table Bristol-Myers Squibb Company Revenue in Hematologic Malignancies Business (2014-2019)(Million US$) Figure Bristol-Myers Squibb Company Revenue Growth Rate in Hematologic Malignancies Business (2014-2019) Table Bristol-Myers Squibb Company Recent Development Table AbbVie, Inc. Company Details Table AbbVie, Inc. Revenue in Hematologic Malignancies Business (2014-2019)(Million US$) Figure AbbVie, Inc. Revenue Growth Rate in Hematologic Malignancies Business (2014-2019) Table AbbVie, Inc. Recent Development Table Novartis AG Company Details Table Novartis AG Revenue in Hematologic Malignancies Business (2014-2019)(Million US$) Figure Novartis AG Revenue Growth Rate in Hematologic Malignancies Business (2014-2019) Table Novartis AG Recent Development Table GlaxoSmithKline PLC Company Details Table GlaxoSmithKline PLC Revenue in Hematologic Malignancies Business (2014-2019)(Million US$) Figure GlaxoSmithKline PLC Revenue Growth Rate in Hematologic Malignancies Business (2014-2019) Table GlaxoSmithKline PLC Recent Development Table Celgene Corporation Company Details Table Celgene Corporation Revenue in Hematologic Malignancies Business (2014-2019)(Million US$) Figure Celgene Corporation Revenue Growth Rate in Hematologic Malignancies Business (2014-2019) Table Celgene Corporation Recent Development Table Johnson & Johnson Services, Inc. Company Details Table Johnson & Johnson Services, Inc. Revenue in Hematologic Malignancies Business (2014-2019)(Million US$) Figure Johnson & Johnson Services, Inc. Revenue Growth Rate in Hematologic Malignancies Business (2014-2019) Table Johnson & Johnson Services, Inc. Recent Development Table Takeda Pharmaceutical Company limited Company Details Table Takeda Pharmaceutical Company limited Revenue in Hematologic Malignancies Business (2014-2019)(Million US$) Figure Takeda Pharmaceutical Company limited Revenue Growth Rate in Hematologic Malignancies Business (2014-2019) Table Takeda Pharmaceutical Company limited Recent Development Table Global Hematologic Malignancies Market Size by Regions (Million US$) 2019-2025 Figure Global Hematologic Malignancies Market Size Share by Regions (2019-2025) Figure Global Hematologic Malignancies Market Size Share by Regions in 2025 Figure United States Hematologic Malignancies Market Size Forecast (2019-2025)(Million USD) Figure Europe Hematologic Malignancies Market Size Forecast (2019-2025)(Million USD) Figure China Hematologic Malignancies Market Size Forecast (2019-2025)(Million USD) Figure Japan Hematologic Malignancies Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Hematologic Malignancies Market Size Forecast (2019-2025)(Million USD) Figure India Hematologic Malignancies Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Hematologic Malignancies Market Size Forecast (2019-2025)(Million USD) Table Global Hematologic Malignancies Market Size by Product (2019-2025) (Million US$) Figure Global Hematologic Malignancies Market Size by Product (2019-2025) Figure Global Hematologic Malignancies Market Size by Product in 2025 Table Global Hematologic Malignancies Market Size by Application (2019-2025) (Million US$) Figure Global Hematologic Malignancies Market Size by Application (2019-2025) Figure Global Hematologic Malignancies Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Pfizer, Inc. F. Hoffmann-LA Roche ltd Sanofi-Aventis Bristol-Myers Squibb Company AbbVie, Inc. Novartis AG GlaxoSmithKline PLC Celgene Corporation Johnson & Johnson Services, Inc. Takeda Pharmaceutical Company limited